fostamatinib

low density lipoprotein receptor ; Mus musculus







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 21700926 The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice. 2011 Sep 2